Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-06-25 Sale |
2020-06-26 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $22 | $32,098 | 79,062 (Direct) |
View |
2020-06-25 Sale |
2020-06-26 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,500 | $20.8 | $51,992 | 537,345 (Direct) |
View |
2020-06-10 Sale |
2020-06-12 5:10 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $22 | $8,822 | 80,521 (Direct) |
View |
2020-06-09 Sale |
2020-06-10 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
156 | $20 | $3,120 | 539,845 (Direct) |
View |
2020-06-05 Sale |
2020-06-09 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
3,433 | $20.17 | $69,251 | 540,001 (Direct) |
View |
2020-06-04 Sale |
2020-06-08 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $20.14 | $13,632 | 95,510 (Direct) |
View |
2020-06-03 Sale |
2020-06-05 4:26 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,800 | $20.09 | $56,250 | 543,434 (Direct) |
View |
2020-06-02 Sale |
2020-06-04 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $20.16 | $7,720 | 96,751 (Direct) |
View |
2020-06-01 Sale |
2020-06-03 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,802 | $20 | $56,040 | 546,234 (Direct) |
View |
2020-05-28 Sale |
2020-06-01 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $20.01 | $16,007 | 97,379 (Direct) |
View |
2020-05-28 Sale |
2020-06-01 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
3,309 | $20.04 | $66,302 | 549,036 (Direct) |
View |
2020-05-28 Sale |
2020-06-01 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $20 | $44,640 | 212,122 (Direct) |
View |
2020-05-27 Sale |
2020-05-29 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $20 | $8,960 | 214,354 (Direct) |
View |
2020-05-26 Sale |
2020-05-28 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $20 | $8,240 | 214,802 (Direct) |
View |
2020-05-26 Sale |
2020-05-28 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
2,500 | $20 | $50,000 | 552,345 (Direct) |
View |
2020-05-12 Sale |
2020-05-12 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $18 | $33,480 | 82,782 (Direct) |
View |
2020-05-11 Sale |
2020-05-12 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
7,500 | $16 | $120,000 | 21,071 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-06-25 Exercise |
2020-06-26 4:17 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $0 | 79,062 (Direct) |
View |
2020-06-25 Exercise |
2020-06-26 4:17 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $4.83 | 79,062 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 4:16 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | LEVIN MARK J Director 10% Owner |
9,285 | $0 | 9,285 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 4:16 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director |
9,285 | $0 | 9,285 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 4:16 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
9,285 | $0 | 9,285 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 4:15 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
9,285 | $0 | 9,285 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 4:15 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
9,285 | $0 | 9,285 (Direct) |
View |
2020-06-10 Exercise |
2020-06-12 5:10 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $0 | 80,521 (Direct) |
View |
2020-06-10 Exercise |
2020-06-12 5:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $4.83 | 80,521 (Direct) |
View |
2020-06-04 Exercise |
2020-06-08 4:17 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $0 | 95,510 (Direct) |
View |
2020-06-04 Exercise |
2020-06-08 4:17 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $4.83 | 95,510 (Direct) |
View |
2020-06-02 Exercise |
2020-06-04 4:16 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $0 | 96,751 (Direct) |
View |
2020-06-02 Exercise |
2020-06-04 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $4.83 | 96,751 (Direct) |
View |
2020-05-28 Exercise |
2020-06-01 4:16 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $0 | 97,379 (Direct) |
View |
2020-05-28 Exercise |
2020-06-01 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $4.83 | 97,379 (Direct) |
View |
2020-05-28 Exercise |
2020-06-01 4:15 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $0 | 212,122 (Direct) |
View |
2020-05-28 Exercise |
2020-06-01 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
2,232 | $7.84 | 212,122 (Direct) |
View |
2020-05-27 Exercise |
2020-05-29 4:15 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $0 | 214,354 (Direct) |
View |
2020-05-27 Exercise |
2020-05-29 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
448 | $7.84 | 214,354 (Direct) |
View |
2020-05-26 Exercise |
2020-05-28 4:16 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $0 | 214,802 (Direct) |
View |
2020-05-26 Exercise |
2020-05-28 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
412 | $7.84 | 214,802 (Direct) |
View |
2020-05-12 Exercise |
2020-05-12 4:15 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $0 | 82,782 (Direct) |
View |
2020-05-12 Exercise |
2020-05-12 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $4.83 | 82,782 (Direct) |
View |